HCPCS Level IIdrugActive
J9119
Inj., cemiplimab-rwlc, 1 mg
BETOS: O1D
Effective: 2019-10-01
Description
Injection, cemiplimab-rwlc, 1 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Libtayo
Manufacturer
Regeneron Pharmaceuticals, Inc.
HCPCS Dosage
1 MG
Billing Units
350.0000
1
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.